Cat. No.: HY-109178

Ifidancitinib

(Synonyms: ATI-50002; ATI-502)

1 Cited Publications

Avis client

Based on 1 publication(s) in Google Scholar

Ifidancitinib (ATI-50002) is an orally available, potent and selective inhibitor of JAK kinase 1/3 that disrupts γc cytokine signaling. Ifidancitinib is used in the research of allergy, asthma, and autoimmune diseases.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

Pureté: 98.01%
CAS No.: 1236667-40-5
Formule: C₂₀H₁₈FN₅O₃
Masse moléculaire:395.39

Stockage:

Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month

Ifidancitinib Chemical Structure

CAS No.: 1236667-40-5

Size

Prix

Stock

Quantité

Amount: USD 0.00

* Veuillez sélectionner la quantité avant d'ajouter des articles.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Activité biologique
- Description
- In Vitro
- In Vivo
- Essai clinique
Chemical Information
Publications (1)
Solvant et solubilité
- In Vitro
Pureté et documentation
Références
Help & FAQs
Classifications
Bioz

Activité biologique

Description

Voir tous les produits spécifiques à Isoform JAK :

In Vitro

Ifidancitinib (0-1000 nM, 1 h) inhibits the JAK1/3 signaling pathway in mouse T cells^[2].
Ifidancitinib (0-1000 nM, 5 days) reduces the number of T cells and inhibits cell proliferation^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis^[2]

Cell Line:

T cell
Concentration:

0, 100, 300, 1000 nM
Incubation Time:

1 h
Result:

Inhibited IL-2-stimulated STAT5 phosphorylation, inhibited IFN-γ signaling, and inhibited STAT1 phosphorylation.

Cell Viability Assay^[2]

Cell Line:

T cell induced by IL-15
Concentration:

100, 300, 1000 nM
Incubation Time:

5 days
Result:

Reduced cell number in a dose-dependent manner.

In Vivo

Ifidancitinib (10-50 mg/kg, oral, single dose) can induce hair regrowth and reduce associated inflammation in mice^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

C3H/HeJ induced by AA^[2]
Dosage:

10, 25, 50 mg/kg; single dose
0.5g/kg; daily; 12 weeks
Administration:

Oral
Result:

Showed that CD44+CD62L- CD8+ T effector/memory cells were significantly reduced in peripheral blood lymphoid organs of mice, the co-inhibitory receptor PD-1 was highly expressed on effector/memory CD8+ T cells, IFN-γ production was reduced, and γc cytokine regulated T cell exhaustion. Reduced inflammatory infiltrates and inflammatory markers, and the proportion of IFN-γ-producing CD8+ T cells was also significantly reduced.

Essai clinique

NCT Number	Sponsor	Condition	Start Date	Phase A549
NCT01329991	Plexxikon\|		2011-05	PHASE1

Chemical Information

CAS No. 1236667-40-5
Appearance Solid
Masse moléculaire 395.39
Formule C₂₀H₁₈FN₅O₃
Color Off-white to light yellow
SMILES

O=C1OC2=CC=C(NC3=NC(NC4=CC(C)=C(F)C(OC)=C4)=NC=C3C)C=C2N1
Synonyms

ATI-50002; ATI-502
Livraison

Room temperature in continental US; may vary elsewhere.

Stockage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Publications (1)

All

Sort by:

Journal Impact Factor

Mol Neurobiol

Pharmacological Inhibition of JAK/STAT-IL2 Axis Alleviated Cisplatin-Induced Ototoxicity. [Abstract]

2025 Nov 19;63(1):83. PMID: 41254428

Solvant et solubilité

In Vitro:

DMSO : 62.5 mg/mL (158.07 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

2.5291 mL

12.6457 mL

25.2915 mL

5 mM

0.5058 mL

2.5291 mL

5.0583 mL

10 mM

0.2529 mL

1.2646 mL

2.5291 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Calculateur de molarité

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Calculateur de dilution

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Pureté et documentation

Select Batch:

Pureté: 99.98%

Assay: 99.98%

ee.: 99.98%

Fiche technique (272 KB)
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Instruction de manipulation (2659 KB)

Références

[1]. Li, Hui; Heckrodt, Thilo J.; Chen, Yan; Mcmurtrie, Darren John; Taylor, Vanessa; Singh, Rajinder; Ding, Pingyu; Yen, Rose.Preparation of phenylaminopyrimidinylaminooxobenzooxazole derivatives for use as JAK kinase inhibitors. WO2012015972A1

[2]. Zhenpeng Dai, et al. Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata. Front Immunol. 2022 Sep 20:13:955038. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	2.5291 mL	12.6457 mL	25.2915 mL	63.2287 mL
	5 mM	0.5058 mL	2.5291 mL	5.0583 mL	12.6457 mL
	10 mM	0.2529 mL	1.2646 mL	2.5291 mL	6.3229 mL
	15 mM	0.1686 mL	0.8430 mL	1.6861 mL	4.2152 mL
	20 mM	0.1265 mL	0.6323 mL	1.2646 mL	3.1614 mL
	25 mM	0.1012 mL	0.5058 mL	1.0117 mL	2.5291 mL
	30 mM	0.0843 mL	0.4215 mL	0.8430 mL	2.1076 mL
	40 mM	0.0632 mL	0.3161 mL	0.6323 mL	1.5807 mL
	50 mM	0.0506 mL	0.2529 mL	0.5058 mL	1.2646 mL
	60 mM	0.0422 mL	0.2108 mL	0.4215 mL	1.0538 mL
	80 mM	0.0316 mL	0.1581 mL	0.3161 mL	0.7904 mL
	100 mM	0.0253 mL	0.1265 mL	0.2529 mL	0.6323 mL

Keywords

Ifidancitinib

1 Cited Publications

100 mg Obtenir un devis

Subscribe to the

MedChemExpress

Newsletter

Nom du produit:
Cat. No.:
Quantité:
MCE Japan Authorized Agent:

Nom du produit:
CAS No.:
Species:
Pureté:
Quantité:

Ifidancitinib

Epigenetics Compound Library

Immunology/Inflammation Compound Library

JAK/STAT Compound Library

Kinase Inhibitor Library

Protein Tyrosine Kinase Compound Library

Stem Cell Signaling Compound Library

Clinical Compound Library

Anti-Aging Compound Library

Drug Repurposing Compound Library

Differentiation Inducing Compound Library

Reprogramming Compound Library

Orally Active Compound Library

Anti-Breast Cancer Compound Library

Anti-Lung Cancer Compound Library

Anti-Pancreatic Cancer Compound Library

Anti-Blood Cancer Compound Library

Anti-Obesity Compound Library

Anti-Liver Cancer Compound Library

Anti-Prostate Cancer Compound Library

Cancer Stem Cells Compound Library

Heterocyclic Compound Library

Autoimmune Disease Compound Library

Highly Selective Inhibitors Library

Anti-Hematopathy Compound Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Drug Repurposing Compound Library Plus

Clinical Compound Library Plus

Bioactive Compound Library

Protein Kinase Compound Library

High-Throughput Bioactive Compound Library

Anti-Rheumatic Arthritis Compound Library

Posttranslational Modification Library

Publications Citing Use of MedChemExpress (MCE) Ifidancitinib

Voir tous les produits spécifiques à Isoform JAK

Activité biologique

Chemical Information

Publications (1)

Solvant et solubilité

Pureté et documentation

Références

Help & FAQs

Complete Stock Solution Preparation Table

Ifidancitinib Related Classifications

HY-109178 Related Classifications